Clinical Trials Search Results

Results 11-20 of 1199 for your search
Show Search Criteria
Ibrutinib and Obinutuzumab with or without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia
Status: Active
Age: 18 to 69 years
Gender: Male or Female
Location: 761 locations
Pembrolizumab in Treating Patients with Locally Advanced Bladder Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 766 locations
Nivolumab after Combined Modality Therapy in Treating Patients with High Risk Stage II-IIIB Anal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 744 locations
Pembrolizumab in Treating Patients with Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 709 locations
Pembrolizumab in Treating Patients with Triple-Negative Breast Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 752 locations